参考文献/References:
Lloyd-Jones D, Adams R J, Brown TM, et al. Executive summary:heart disease and stroke statistics——2010 update:a report from the American Heart Association. Circulation, 201 O, 12 l(7):948-954.
[2] 管阳太.动脉粥样硬化血栓形成与脑卒中的抗血小板治疗.上海医学,2009(4):271-275.
[3] Libby P. Current concepts of the pathogenesis of the acute coronary. syndromes. Circulation, 2001, 104(3):365-372.
[4] Cheng C, Tempel D, van Haperen R, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation, 2006, 113(23):2744-2753.
[5] Muller JE, Toiler GH. Triggering and hourly variation of onset of arterial thrombosis. Ann Epidemiol, 1992, 2(4):393-405.
[6] Muller JE, Kaufnmnn PG, Luepker RV, et al. Mechanisms precipitating acute cardiac events:review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms precipitating acute cardiac events participants. Circulation, 1997, 96(9):3233-3239.
[7] Matter CM, Stuber M, Nahrendorf M. Imaging of the unstable plaque:how far have we got?. Eur Heart J, 2009, 30(21):2566-2574.
[8] 宋桂芹,王拥军.识别易损斑块的影像技术.中华老年心脑血管病杂志,2008,10(11):875-877.
[9] Budoff M J, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography:a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation, 2006, 114(16):1761-1791.
[10] Ohtsuki K, Hayase M, Akashi K, et al. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotie lesions:an autoradiographic study. Circulation, 2001, 104(2):203-208.
[11] Iuliano L, Signore A, Vallabajosula S, et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis, 1996, 126(1):131-141.
[12] Johnson LL, Sehofield L, Donahay T, et al. ^99mTc-annexin V imaging for in vivo detection of atherosclero’de lesions in porcine coronary arteries. J Nuel Med, 2005, 46(7):1186-1193.
[13] Kietselaer BL, Reutelingsperger CP, Heidendal GA, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 patients with carotid-artery atheroselerosis. N Engl J Med, 2004, 350(14):1472-1473.
[14] Ogawa M, Ishino S, Mukai T, et al. (18)F-FDG accumulation in atherosclerotie plaques:immunohistoehemieal and PET imaging study. J Nuel Med, 2004, 45(7):1245-1250.
[15] Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivomeasurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol, 2005, 12(3):294301.
[16] Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coil Cardiol, 2006, 48(9):1818-1824.
[17] Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atheroscterotic plaques with FDG-microPET:No FDG accumulation. Atherosclerosis, 2007, 192(2):275-282.
[18] Manieri M, Murano I, Fianchini A, et ah Morphological and immunohistochemicat features of brown adipocytes and preadipocytes in a case of human hibernoma. Nutr Metab Cardiovasc Dis, 2010, 20(8):567-574.
[19] Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab, 2007, 293(2):E444-E452.
[20] Graebe M, Pedersen SF, Borgwardt L, et al. Moleeular pathology in vulnerable carotid plaques:correlation with[18]-fluorodeoxvglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg, 2009, 37(6):714-721.
[21] Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed, 2006, 19(6):636-654.
[22] Yuan C, Oikawa M, Miller Z, et al. MRI of carotid atherosclerosis. J Nucl Cardiol, 2008, 15(2):266-275.
[23] Chu B, Kampschulte A, Ferguson MS, et al. Hemorrhage in the atherosclerotic carotid plaque:a high-resolution MRI study. Stroke, 2004, 35(5):1079-1084.
[24] Cai JM, Hatsukami TS, Ferguson MS, et al. Classification of human carotid atherosclerotic lesions with in vivo muhicontrast magnetic resonance imaging. Circulation, 2002, 106(11):1368-1373.
[25] 赵辉林,许建荣.3.0T高分辨MRI对颈动脉斑块分型的研究.中国医学计算机成像杂志,2007,13(3):158-162.
[26] Yarnykh VL, Terashima M, Hayes CE, et al. Muhicontrast blackblood MR/of carotid arter/es:comparison between 1.5 and 3 tesla magnetic field strengths. J Magn Resort Imaging, 2006, 23(5):691-698.
[27] Redgrave JN, Gallagher P, Lovett JK, et al. Critical cap thickness and rupture in symptomatic carotid plaques:The oxford plaque study. Stroke, 2008, 39(6):1722-1729.
[28] No authors listed. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA, 1995,273(18):1421-1428.
[29] European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptonmtic carotid stenosis:final results of the MRC European Carotid Surgery Trial (ECST). Lancet, 1998, 351(9113):1379-1387.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[6]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[7]张巍,杨珂.18f正电子放射性药物生产及使用中医务人员的受照剂量研究[J].国际放射医学核医学杂志,2015,39(5):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
zhang wei,yang ke..the research of radiation dose of 18f-fdg to pet/ct related personnel[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
[8]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[9]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[10]孙萌萌,付畅,史大鹏,等.不同分期肺腺癌患者大脑静息葡萄糖代谢改变研究[J].国际放射医学核医学杂志,2015,39(6):437.[doi:10.3760/cma.j.issn.1673-4114.2015.06.001]
Sun Mengmeng,Fu Chang,Shi Dapeng,et al.Preliminary study of metabolic changes in brain glucose of patients with lung adenocarcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):437.[doi:10.3760/cma.j.issn.1673-4114.2015.06.001]
[11]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[12]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[13]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[14]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[15]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[16]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[17]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[18]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[19]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[20]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]